HYD Stock Overview
Hydrix Limited provides product design, engineering, and regulatory consulting services in Australia, Singapore, Europe, North America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Hydrix Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.015 |
| 52 Week High | AU$0.041 |
| 52 Week Low | AU$0.015 |
| Beta | 1.63 |
| 1 Month Change | -21.05% |
| 3 Month Change | -28.57% |
| 1 Year Change | -60.53% |
| 3 Year Change | -91.67% |
| 5 Year Change | -94.23% |
| Change since IPO | -99.71% |
Recent News & Updates
Shareholder Returns
| HYD | AU Electronic | AU Market | |
|---|---|---|---|
| 7D | -6.3% | -0.5% | 0.4% |
| 1Y | -60.5% | 39.9% | 6.0% |
Return vs Industry: HYD underperformed the Australian Electronic industry which returned 39.9% over the past year.
Return vs Market: HYD underperformed the Australian Market which returned 6% over the past year.
Price Volatility
| HYD volatility | |
|---|---|
| HYD Average Weekly Movement | 12.7% |
| Electronic Industry Average Movement | 9.2% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: HYD's share price has been volatile over the past 3 months.
Volatility Over Time: HYD's weekly volatility (13%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 70 | n/a | www.hydrix.com |
Hydrix Limited provides product design, engineering, and regulatory consulting services in Australia, Singapore, Europe, North America, and internationally. The company operates through three segments: Hydrix Services, Hydrix Medical, and Hydrix. Its products portfolio comprises The GUARDIAN, a cardiac monitoring device that alerts and warns patients to seek medical attention for acute coronary syndrome (ACS), including silent heart attacks; LUDO, a customizable plug-and-play platform that offers critical tools to start MCS pump development; EchoSolv, a cloud-based decision support platform, which provides physicians with tools to identify patients at-risk of structural heart disease; and Implicity, an AI-driven RM solution that delivers cardiovascular monitoring technology and data management tools, which supports health professionals in the diagnosis, rehabilitation, and surveillance of cardiovascular patients.
Hydrix Limited Fundamentals Summary
| HYD fundamental statistics | |
|---|---|
| Market cap | AU$4.07m |
| Earnings (TTM) | -AU$2.23m |
| Revenue (TTM) | AU$12.66m |
0.3x
P/S Ratio-1.7x
P/E RatioIs HYD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HYD income statement (TTM) | |
|---|---|
| Revenue | AU$12.66m |
| Cost of Revenue | AU$1.04m |
| Gross Profit | AU$11.62m |
| Other Expenses | AU$13.85m |
| Earnings | -AU$2.23m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0088 |
| Gross Margin | 91.76% |
| Net Profit Margin | -17.61% |
| Debt/Equity Ratio | 151.4% |
How did HYD perform over the long term?
See historical performance and comparison